United States v. Babarinde

126 F. Supp. 3d 22, 2015 U.S. Dist. LEXIS 116421, 2015 WL 5158972
CourtDistrict Court, District of Columbia
DecidedSeptember 1, 2015
DocketCriminal No. 2014-0026
StatusPublished
Cited by1 cases

This text of 126 F. Supp. 3d 22 (United States v. Babarinde) is published on Counsel Stack Legal Research, covering District Court, District of Columbia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Babarinde, 126 F. Supp. 3d 22, 2015 U.S. Dist. LEXIS 116421, 2015 WL 5158972 (D.D.C. 2015).

Opinion

*24 MEMORANDUM OPINION

REGGIE B. WALTON, United States District Judge

Pending before the Court is the defendants’ oral motion for access to the medical records of the government’s prior confidential informant and . now witness, Rhonda Talley. See Transcript of May 18, 2015 Jury Selection (“May Tr.”) at 38:3, 38:18-19; 39:7-9; see also Brief in Support of Motion for Production of Mental Health Records (“Defs.’ Br.”) at 2, ¶ 6. After carefully considering the parties’ submissions in conjunction with the arguments presented during both the May 18, 2015 competency hearing and the August 4, 2015 motions hearing. 1 the Court denies the defendants’ motion.

BACKGROUND

The defendants have each been indicted and charged with Conspiracy to Defraud the United States in violation of 18 U.S.C. § 371, Health Care Fraud in violation of 18 U.S.C. § 1347. and Illegal Payment in Connection with Federal Health Care Programs in violation of 42 U.S.C. § 1320a-7b(b)(2). See Indictment ¶¶ 1-23; see also Defs.’ Br. at 1 ¶ 1. As grounds for acquiring Ms. Talley’s medical records, the defendants contend that they are entitled to the records because they are challenging Ms. Talley’s competency to testify as a government witness during their trial. Upon the defendants learning about Ms. Talley’s psychological diagnosis and challenging her competency, the Court conducted a competency hearing. See generally May Tr. During the competency hearing, Ms. Talley provided testimony about her recollection of the events about which she would be testifying, see e.g., id. at 5:3 — 9:3; 9:10-23. including her memory of her participation in the government’s investigation, see id. at 10:24-13:8, her psychological diagnoses, see id. at 17:3-6. the medication she takes, see id. at 14:4-17:14 and the impact her medications have on her memory, see id.

At the conclusion of Ms. Talley’s testimony, the defendants requested access to her medical records, see May Tr. at 38:3. 38:18-19, 39:7-9, and the government agreed that, in light of the circumstances, the defendants had the “right to request the records,” see id. at 42:18-19. However, following the hearing, the government informed the Court that Ms. Talley did not consent to the release of her medical records, citing the psychotherapist-patient privilege. See Email from government to the Court (May 28, 2015, 4:30 P.M. EST) (on file with Court); see generally Talley Opp’n. Counsel was then appointed to represent Ms. Talley and after the matter was fully briefed, the Court held a hearing to assess whether the defendants are entitled to Ms. Talley’s medical records. See Aug. 4, 2015 Minute Entry.

DISCUSSION

The “psychotherapist-patient privilege” protects “confidential communications between a licensed psychotherapist [and licensed social workers] and [a] patient! disclosed] in the course of diagnosis or treatment.” See Jaffee v. Redmond, 518 U.S. 1, 15, 10-18, 116 S.Ct. 1923, 135 L.Ed.2d 337 (1996). Records of these types “are protected from compelled disclosure under Rule 501 of the Federal Rules of Evidence.” 2 Id. (emphasis added). *25 However, “[a] patient may waive the psychotherapist-patient privilege by knowingly and voluntarily relinquishing it, [which] may occur when the substance of therapy sessions is disclosed to unrelated third parties, ... or when the privilege is not properly asserted during testimony.” United States v. Bolander, 722 F.3d 199, 223 (4th Cir.2013) (citing United States v. Hayes, 227 F.3d 578, 586 (6th Cir.2000)) (emphasis added), cert. denied, — U.S. —, 134 S.Ct. 549, 187 L.Ed.2d 392 (2013) “The burden rests on the person invoking the privilege to demonstrate its applicability, including the absence of any waiver of it.” Id. at 222.

The defendants agree that as a general matter Ms. Talley’s medical records are protected by the psychotherapist-patient privilege. See Defs.’ Br. at 2-3. They argue, however, that they are nonetheless entitled to the medical records because Ms. Talley waived the privilege by: (1) “testif[ying] in open-court” at the May 18, 2015 competency hearing, id. at 6; (2) “discussing] her mental condition with the prosecuting attorneys and the FBI agents when she was brought in to discuss her testimony at trial,” id. at 5; and (3) applying for and receiving Supplemental Security Income (“SSI”) benefits from the Social Security Administration (“SSA”), id. at 4-5. Ms. Talley, however, argues that “[i]t is axiomatic that a waiver cannot be operational unless it is knowingly and intelligently made,” Talley Opp’n at 1, and that she “did not contemplate disclosure of her treatment in a public forum ... [as each of] Ms. Talley’s activities in these other contexts were made long before counsel was appointed for her[ 3 ] so it is impossible to state that she has knowingly and intelligently waived her privilege,” 4 id. at 1-2.

A. Ms. Talley’s Testimony During the May 18, 2015 Competency Hearing

Upon reviewing Ms. Talley’s May 18, 2015 testimony, the Court cannot conclude that Ms. Talley waived her right to assert the psychotherapist-patient privilege because at no point was “the substance of [her] therapy sessions” disclosed. Bolander, 722 F.3d at 223. Moreover, Ms. Talley did not reveal any relevant “confidential communications between” herself and her doctors. Jaffee, 518 U.S. at 15, 116 S.Ct. 1923. While it is certainly true that she identified her mental health diagnoses and described to the Court what medications she was taking and the impact those medications had on her emotional and cognitive abilities, see May Tr. at 14:4— 18:8, Ms. Talley did not disclose “the substance of [any of her] therapy session[s],” Bolander, 722 F.3d at 222. And while Ms. Talley certainly acknowledged that her *26 “doctor said that depression ...

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Contreras v. Mote
E.D. California, 2020

Cite This Page — Counsel Stack

Bluebook (online)
126 F. Supp. 3d 22, 2015 U.S. Dist. LEXIS 116421, 2015 WL 5158972, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-babarinde-dcd-2015.